Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Tele2 in connection with its notes issuance and tender offer
Mandate

Vinge advises Tele2 in connection with its notes issuance and tender offer

May 22, 2023 Banking and Finance Corporate Tax

Vinge advises Tele2 AB (publ) in connection with its issuance of senior unsecured fixed rate notes in an amount of EUR 500 million and its parallel tender offer in respect of its previously issued notes due 2024.

The proceeds from the new notes, which were issued under Tele2’s EUR 5 billion EMTN-program, are applied towards the financing of the tender offer and for general corporate purposes, and the notes will be listed on the Luxembourg Stock Exchange. The notes have a tenor of six and a half years and were issued with a coupon of 3.75 per cent.

Vinge’s team consisted of Louise Brorsson Salomon, Lionardo Ojeda, Ida Redander (Banking and Finance), Victor Ericsson and Emelie Svanberg (Tax)

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025